Scholarlink

<p>The gut microbiome’s capacity to produce immunomodulatory metabolites is increasingly recognized as a potent determinant of cancer immunotherapy outcomes. This review uniquely integrates emerging data on engineered microbial metabolite production—through synthetic biology, dietary modulation, rational probiotics, and postbiotic therapies—and maps their clinical translation as immunotherapeutic agents. We critically analyze short-chain fatty acids, tryptophan metabolites, bile acids, and polyamines, highlighting their context-specific immune effects and biomarker potential. Moreover, we outline innovative engineering strategies, precision microbiome tools, and personalized therapeutic platforms that reposition microbial metabolites as programmable bioactive drugs. This synthesis aims to guide the next phase of clinical application and regulatory development in microbiome-informed oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Engineering microbial metabolites to modulate tumor immunity and advance cancer immunotherapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月4日

查看全文
  • Victor Uchenna Chigozie,
  • Charles Okechukwu Esimone

摘要

The gut microbiome’s capacity to produce immunomodulatory metabolites is increasingly recognized as a potent determinant of cancer immunotherapy outcomes. This review uniquely integrates emerging data on engineered microbial metabolite production—through synthetic biology, dietary modulation, rational probiotics, and postbiotic therapies—and maps their clinical translation as immunotherapeutic agents. We critically analyze short-chain fatty acids, tryptophan metabolites, bile acids, and polyamines, highlighting their context-specific immune effects and biomarker potential. Moreover, we outline innovative engineering strategies, precision microbiome tools, and personalized therapeutic platforms that reposition microbial metabolites as programmable bioactive drugs. This synthesis aims to guide the next phase of clinical application and regulatory development in microbiome-informed oncology.